RNA Interference Technology Market - Global Forecast 2026-2032

The RNA Interference Technology Market is evolving rapidly as scientific advances, regulatory changes, and new commercialization models increase complexity and opportunity for global life science organizations. Senior leaders must adapt investment and operational strategies to capture emerging value and address shifting risks in this critical therapeutic segment.

Market Snapshot: RNA Interference Technology Market Size and Growth

The global RNA Interference Technology Market is on a steady upward trajectory, valued at USD 3.55 billion in 2025 and anticipated to reach USD 3.87 billion in 2026. This sector is forecast to expand at a compound annual growth rate (CAGR) of 9.05%, resulting in a projected market value of USD 6.51 billion by 2032. Robust adoption in clinical development, drug discovery, and advanced therapy is fueling this expansion, highlighting the growing demand for specialized RNAi solutions and targeted investment by pharmaceutical and biotechnology stakeholders.

Scope & Segmentation: Insights Across the RNA Interference Ecosystem

This analysis delivers a structured overview for senior decision-makers seeking actionable intelligence on the RNA Interference Technology Market. The study addresses technology adoption, regulatory requirements, and operational best practices while mapping out the critical segments and global footprints transforming the landscape:

Molecule Classes: Covers MicroRNA, short hairpin RNA (shRNA), and small interfering RNA (siRNA), each pivotal in gene regulation, silencing efficiency, and applications from research to advanced therapies.
Routes of Administration: Discusses intramuscular, intrathecal, and intravenous options, with analysis of implications for clinical outcomes and patient access pathways.
Delivery Platforms: Evaluates lipid nanoparticles, targeted conjugates, viral vectors, non-viral systems, and the emergence of exosome-based delivery, enabling both localized and systemic RNAi administration.
Applications: Focuses on deployment in drug discovery, R&D, and pipelines targeting diverse disease indications, highlighting the need for robust evidence standards and streamlined regulatory processes.
End User Needs: Details operational requirements for contract research organizations, clinical centers, hospitals, and pharma-biotech firms, emphasizing scalability, compliance, and commercial readiness.
Regional Dynamics: Reviews research and manufacturing trends in the Americas, Europe, Middle East & Africa, and Asia-Pacific, providing context for regional strategies and market access initiatives.

Key Takeaways for Strategic Leaders

Engineering progress and enhanced delivery platforms are broadening the applicability of RNA interference technologies beyond traditional domains.
Partnerships between research-driven entities and manufacturing providers are accelerating translation from discovery to clinical deployment, enhancing development efficiency.
Heightened regulatory scrutiny is driving the uptake of standardized analytic and validation frameworks, vital for early clinical studies.
Strengthening procurement through diversified sourcing and establishing qualified regional suppliers mitigates supply chain vulnerability and improves operational resilience.
Collaboration between biopharma innovators, contract service organizations, and technology specialists increases development speed and enables more effective commercialization strategies.

Tariff Impact and Operational Resilience

Recent U.S. tariff policy changes in 2025 have reshaped RNAi technology supply chains, increasing the complexity and cost structure for sourcing raw materials. Organizations are responding by reassessing procurement practices, diversifying suppliers, and expediting validation of new sources. Investments in expanded regional production capabilities are helping manufacturers stabilize pricing and maintain continuity amid cross-border trade fluctuations. These adaptations improve resilience and reinforce strategic planning to manage tariff-related risks from early project stages.

Primary Methodology & Data Sources

The research approach integrates structured expert interviews, comprehensive technical literature review, supply chain analysis, and examination of regulatory documents. Relevant case studies and trade policy data supplement these methods to ensure balanced, actionable insights into market performance and potential operational risks.

Why This RNA Interference Technology Market Report Matters

Supports strategic alignment by pinpointing where specific molecule platforms, delivery technologies, and regional initiatives can create translational value and competitive advantage.
Enables forward-looking compliance and risk strategies in light of regulatory adjustments, tariff impacts, and unique challenges relevant to RNAi applications.
Facilitates prioritization of R&D partnerships and investments, contributing to more effective clinical development, accelerated timelines, and streamlined market access.

Conclusion

With continual advances in RNA interference technologies, organizations that synchronize scientific, operational, and regulatory strengths are well positioned to realize new growth and clinical impact across global health markets.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. RNA Interference Technology Market, by Molecule Type

8.1. MicroRNA (miRNA)
8.2. Short Hairpin RNA (shRNA)
8.2.1. Non-Viral Delivery shRNA
8.2.2. Viral Delivery shRNA
8.3. Small Interfering RNA (siRNA)
8.3.1. Conjugated siRNA
8.3.2. Non-Conjugated siRNA

9. RNA Interference Technology Market, by Route Of Administration

9.1. Intramuscular (IM) Injection
9.2. Intrathecal (IT) Administration
9.3. Intravenous (IV) Injection

10. RNA Interference Technology Market, by Delivery Method

10.1. Direct Naked RNAi Delivery
10.2. Exosome-Based RNAi Therapy
10.3. Nanoparticle-Based Delivery
10.4. Viral Vector-Based Delivery

11. RNA Interference Technology Market, by Application

11.1. Drug Discovery
11.1.1. Lead Optimization
11.1.2. Target Identification
11.2. Research & Development
11.2.1. Gene Function Studies
11.2.2. Pathway Analysis
11.3. Therapeutics

12. RNA Interference Technology Market, by End-User

12.1. Contract Research Organizations
12.2. Hospitals & Clinics
12.3. Pharmaceutical & Biotechnology Companies

13. RNA Interference Technology Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. RNA Interference Technology Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. RNA Interference Technology Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States RNA Interference Technology Market
17. China RNA Interference Technology Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Alnylam Pharmaceuticals, Inc.
18.6. AMSBIO
18.7. Arbutus Biopharma Corporation
18.8. Arcturus Therapeutics Holdings Inc.
18.9. Arrowhead Pharmaceuticals, Inc.
18.10. Atalanta Therapeutics
18.11. Bioneer Corporation
18.12. Dicerna Pharmaceuticals, Inc.
18.13. Gradalis, Inc.
18.14. Horizon Therapeutics plc
18.15. Ionis Pharmaceuticals, Inc.
18.16. Merck KGaA
18.17. Novartis AG
18.18. Nutcracker Therapeutics, Inc.
18.19. Phio Pharmaceuticals Corp.
18.20. ProQR Therapeutics N.V.
18.21. Sanofi S.A.
18.22. Silence Therapeutics PLC
18.23. Sirnaomics, Inc.
18.24. Thermo Fisher Scientific Inc.
18.25. Vir Biotechnology, Inc.

List of Figures

FIGURE 1. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MICRORNA (MIRNA), BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MICRORNA (MIRNA), BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MICRORNA (MIRNA), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 10. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NON-VIRAL DELIVERY SHRNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NON-VIRAL DELIVERY SHRNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NON-VIRAL DELIVERY SHRNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY VIRAL DELIVERY SHRNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY VIRAL DELIVERY SHRNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY VIRAL DELIVERY SHRNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 20. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY CONJUGATED SIRNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY CONJUGATED SIRNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY CONJUGATED SIRNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NON-CONJUGATED SIRNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NON-CONJUGATED SIRNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NON-CONJUGATED SIRNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY INTRAMUSCULAR (IM) INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY INTRAMUSCULAR (IM) INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY INTRAMUSCULAR (IM) INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY INTRATHECAL (IT) ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY INTRATHECAL (IT) ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY INTRATHECAL (IT) ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY INTRAVENOUS (IV) INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY INTRAVENOUS (IV) INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY INTRAVENOUS (IV) INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DIRECT NAKED RNAI DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DIRECT NAKED RNAI DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DIRECT NAKED RNAI DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY EXOSOME-BASED RNAI THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY EXOSOME-BASED RNAI THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY EXOSOME-BASED RNAI THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NANOPARTICLE-BASED DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NANOPARTICLE-BASED DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NANOPARTICLE-BASED DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY VIRAL VECTOR-BASED DELIVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY VIRAL VECTOR-BASED DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY VIRAL VECTOR-BASED DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TARGET IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TARGET IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY GENE FUNCTION STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY GENE FUNCTION STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY GENE FUNCTION STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY PATHWAY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY PATHWAY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY PATHWAY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 87. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 88. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 124. EUROPE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. EUROPE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 126. EUROPE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 127. EUROPE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 128. EUROPE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 129. EUROPE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 130. EUROPE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. EUROPE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 132. EUROPE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 133. EUROPE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 144. AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 146. AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 147. AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 148. AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 149. AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 150. AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 152. AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 153. AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. ASEAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. ASEAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 167. ASEAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 168. ASEAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 169. ASEAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 170. ASEAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 171. ASEAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 172. ASEAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 173. ASEAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 174. ASEAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 175. GCC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. GCC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 177. GCC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 178. GCC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 179. GCC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 180. GCC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 181. GCC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. GCC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 183. GCC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 184. GCC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 195. BRICS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. BRICS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 197. BRICS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 198. BRICS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 199. BRICS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 200. BRICS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 201. BRICS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 202. BRICS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 203. BRICS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 204. BRICS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 205. G7 RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 206. G7 RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 207. G7 RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 208. G7 RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 209. G7 RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 210. G7 RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 211. G7 RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 212. G7 RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 213. G7 RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 214. G7 RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 215. NATO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. NATO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 217. NATO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 218. NATO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 219. NATO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 220. NATO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 221. NATO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. NATO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 223. NATO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 224. NATO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 236. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 237. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 238. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SHORT HAIRPIN RNA (SHRNA), 2018-2032 (USD MILLION)
TABLE 239. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SMALL INTERFERING RNA (SIRNA), 2018-2032 (USD MILLION)
TABLE 240. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 241. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 242. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 243. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 244. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 245. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this RNA Interference Technology market report include:

Alnylam Pharmaceuticals, Inc.
AMSBIO
Arbutus Biopharma Corporation
Arcturus Therapeutics Holdings Inc.
Arrowhead Pharmaceuticals, Inc.
Atalanta Therapeutics
Bioneer Corporation
Dicerna Pharmaceuticals, Inc.
Gradalis, Inc.
Horizon Therapeutics plc
Ionis Pharmaceuticals, Inc.
Merck KGaA
Novartis AG
Nutcracker Therapeutics, Inc.
Phio Pharmaceuticals Corp.
ProQR Therapeutics N.V.
Sanofi S.A.
Silence Therapeutics PLC
Sirnaomics, Inc.
Thermo Fisher Scientific Inc.
Vir Biotechnology, Inc.

Table Information

Report Attribute	Details
No. of Pages	180
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 3.87 Billion
Forecasted Market Value ( USD ) by 2032	$ 6.51 Billion
Compound Annual Growth Rate	9.0%
Regions Covered	Global
No. of Companies Mentioned	22

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3504EUR$3,939USD£3,037GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3779EUR$4,249USD£3,276GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5123EUR$5,759USD£4,440GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6199EUR$6,969USD£5,372GBP

Market Snapshot: RNA Interference Technology Market Size and Growth

Scope & Segmentation: Insights Across the RNA Interference Ecosystem

Key Takeaways for Strategic Leaders

Tariff Impact and Operational Resilience

Primary Methodology & Data Sources

Why This RNA Interference Technology Market Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

RNA Interference Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

RNA Interference- Pipeline Insight, 2025

RNA Interference (RNAi) - Global Strategic Business Report

Ribonucleic Acid (RNA) Therapy Clinical Trials Market Report 2025

Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Report 2025